Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29208, USA.
Brain Behav Immun. 2012 Jan;26(1):72-82. doi: 10.1016/j.bbi.2011.07.236. Epub 2011 Jul 23.
Resveratrol, a naturally occurring polyphenol has received significant attention as a potent anti-inflammatory agent. Inflammatory bowel disease (IBD) is a chronic intestinal inflammation caused by hyperactivated effector immune cells that produce proinflammatory cytokines. Myeloid derived suppressor cells (MDSCs) are a heterogeneous population characterized by the co-expression of CD11b(+) and Gr-1(+) and have long been known for their immunosuppressive function. We report that resveratrol effectively attenuated overall clinical scores as well as various pathological markers of colitis in IL-10(-/-) mice by down regulating Th1 responses. Resveratrol lessened the colitis-associated decrease in body weight and increased levels of serum amyloid A (SAA), CXCL10 and colon TNF-α, IL-6, RANTES, IL-12 and IL-1β concentrations. After resveratrol treatment, the percentage of CXCR3 expressing T cells was decreased in the spleen, mesenteric lymph nodes (MLN), and intestinal lamina propria (LP). However, the percentage and absolute numbers of CD11b(+) and Gr-1(+)cells in the lamina propria (LP) and spleen were increased after resveratrol treatment as compared with the vehicle treatment. Co-culture of resveratrol-induced CD11b(+) Gr-1(+) cells with T cells, attenuated T cell proliferation, and most importantly reduced IFN-γ and GM-CSF production by LP derived T cells from vehicle treated IL-10(-/-) mice with chronic colitis. The current study suggests that administration of resveratrol into IL-10(-/-) mice induces immunosuppressive CD11b(+) Gr-1(+) MDSCs in the colon, which correlates with reversal of established chronic colitis, and down regulation of mucosal and systemic CXCR3(+) expressing effector T cells as well as inflammatory cytokines in the colon. The induction of immunosuppressive CD11b(+) Gr-1(+) cells by resveratrol during colitis is unique, and suggests an as-yet-unidentified mode of anti-inflammatory action of this plant polyphenol.
白藜芦醇是一种天然存在的多酚,作为一种有效的抗炎剂受到了广泛关注。炎症性肠病(IBD)是一种由过度激活的效应免疫细胞产生促炎细胞因子引起的慢性肠道炎症。髓系来源的抑制细胞(MDSCs)是一种异质性群体,其特征是共同表达 CD11b(+)和 Gr-1(+),并长期以来因其免疫抑制功能而闻名。我们报告称,白藜芦醇通过下调 Th1 反应,有效减轻了 IL-10(-/-)小鼠的整体临床评分以及各种结肠炎的病理标志物。白藜芦醇减轻了结肠炎相关的体重减轻,并增加了血清淀粉样蛋白 A(SAA)、CXCL10 和结肠 TNF-α、IL-6、RANTES、IL-12 和 IL-1β的浓度。经过白藜芦醇治疗后,脾脏、肠系膜淋巴结(MLN)和肠固有层(LP)中表达 CXCR3 的 T 细胞的百分比降低。然而,与载体治疗相比,白藜芦醇治疗后 LP 和脾脏中 CD11b(+)和 Gr-1(+)细胞的百分比和绝对数量增加。与用载体处理的慢性结肠炎 IL-10(-/-)小鼠的 LP 来源的 T 细胞共培养时,白藜芦醇诱导的 CD11b(+)Gr-1(+)细胞减弱了 T 细胞的增殖,最重要的是降低了 IFN-γ和 GM-CSF 的产生。本研究表明,将白藜芦醇给予 IL-10(-/-)小鼠可诱导结肠中免疫抑制性 CD11b(+)Gr-1(+)MDSCs,这与逆转已建立的慢性结肠炎以及下调粘膜和全身 CXCR3(+)表达的效应 T 细胞以及结肠中的炎症细胞因子有关。白藜芦醇在结肠炎期间诱导免疫抑制性 CD11b(+)Gr-1(+)细胞是独特的,这表明这种植物多酚具有尚未确定的抗炎作用模式。